ICYMI: Neuraxpharm and Minoryx’s Special Information Film Raises Leukodystrophy Awareness
source: pixabay.com

ICYMI: Neuraxpharm and Minoryx’s Special Information Film Raises Leukodystrophy Awareness

Rare Disease Day may be long past in February, but the fight for rare disease awareness continues. Earlier this year, specialty pharmaceutical company Neuraxpharm Group ("Neuraxpharm") and biotechnology company Minoryx…

Continue Reading ICYMI: Neuraxpharm and Minoryx’s Special Information Film Raises Leukodystrophy Awareness
Rare Community Profiles: How Two Parents Are Working to Change the Narrative Around CASK Gene Disorder
Fotocitizen / Pixabay

Rare Community Profiles: How Two Parents Are Working to Change the Narrative Around CASK Gene Disorder

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: How Two Parents Are Working to Change the Narrative Around CASK Gene Disorder
Raising Vanishing White Matter Disease (VWM) Awareness: How Ella’s Pitch Catalyzed Change
Source: pixabay.com

Raising Vanishing White Matter Disease (VWM) Awareness: How Ella’s Pitch Catalyzed Change

When you’re a baseball fan, any chance you get to join in and really experience the game is amazing. Seven-year-old Ella McKee has always been fascinated by baseball. She loves…

Continue Reading Raising Vanishing White Matter Disease (VWM) Awareness: How Ella’s Pitch Catalyzed Change
OTL-200 for Metachromatic Leukodystrophy Investigational New Drug Application Gets Approved
qimono / Pixabay

OTL-200 for Metachromatic Leukodystrophy Investigational New Drug Application Gets Approved

  In a recent press release, gene therapy company Orchard Therapeutics ("Orchard") announced that the FDA approved Orchard's Investigational New Drug (IND) application for OTL-200. This gene therapy solution is…

Continue Reading OTL-200 for Metachromatic Leukodystrophy Investigational New Drug Application Gets Approved
Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology
source: pixabay.com

Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology

As reported in Biospace, the National Organization for Rare Disorders (NORD) has just opened registration for patients to take part in a natural history study on metachromatic leukodystrophy (MLD), a…

Continue Reading Natural History Study on Metachromatic Leukodystrophy To Use Innovative Methodology

New Reduced-Intensity Conditioning for HSCT Found Beneficial for 20 Rare Diseases

A recent study published in the journal Blood Advances has documented that hematopoietic stem cell transplantation (HSCT) is both safe and effective for children with many different kinds of inherited nonmalignant conditions…

Continue Reading New Reduced-Intensity Conditioning for HSCT Found Beneficial for 20 Rare Diseases
Defective Immune Cells Cause Rare Childhood Neurological Disorders
https://pixabay.com/en/child-cute-dad-father-love-man-1835730/

Defective Immune Cells Cause Rare Childhood Neurological Disorders

A recent University of Sheffield news release explores findings which highlight a potential cause of leukodystrophies: immune cells. This group of rare childhood neurological disorders impacts the myelin sheath, the…

Continue Reading Defective Immune Cells Cause Rare Childhood Neurological Disorders
OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)
source: pixabay.com

OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)

  The development of treatments and medicines for diseases can take a long time. These treatments come from many hours of research, studies, trials, and waiting for approval from the…

Continue Reading OTL-200 Granted Accelerated Assessment for Treatment of Metachromatic Leukodystrophy (MLD)